Fig. 5From: Identification of biomarkers and drug repurposing candidates based on an immune-, inflammation- and membranous glomerulonephritis-associated triplets network for membranous glomerulonephritisDrug repurposing candidates for MGN based on dysregulated IIMATs. a The drug-related dysregulated IIMAT network for MGN. b The drugs with high degree in the drug-related dysregulated IIMAT network. c The Tamoxifen-related sub-network extracted from drug-related dysregulated IIMAT network. d The heat map shows the expression of genes in Tamoxifen-related sub-networkBack to article page